Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AquaVita NextGen vs GobyMeds

AquaVita NextGen
Graded #416

Lower grade

vs+12.600000000000009
GobyMeds
Graded #140

Higher grade

The verdict

GobyMeds takes it — 68.9/100 to 56.3/100.

GobyMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Affordable telehealth provider offering compounded semaglutide only.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGobyMeds +44
23
67
Dose & formulationEven
75
75
Clinical oversightEven
82
82
Labs & monitoringEven
53
53
FulfillmentGobyMeds +8
62
70
Contract termsGobyMeds +8
47
55
AquaVita NextGen · left barGobyMeds · right bar

The numbers

MetricAquaVita NextGenGobyMeds
WeighScore56.3/10068.9/100
GradeCC
Scorecard rank#416#140
Semaglutide$375/mo (first-month rate, compounded)$169/mo (all doses, compounded)
Tirzepatide$320/mo (starting dose, 3-month plan, compounded)$299/mo (all doses, compounded)
Coverage5 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only
AquaVita NextGen

Graded #416 · C

Strengths

  • Physical address in Lake Forest CA
  • Named medical director (Dr. Steve Groke)
  • Both semaglutide and tirzepatide including ODT tablets
  • Compounding disclaimer present on site

Where it loses points

  • Only 5 states (AZ, CA, FL, TX, NV)
  • No LegitScript or PCAB accreditation
  • Primarily a local medspa expanding into telehealth
  • Only a first-month semaglutide price ($375, originally $499) is published; ongoing monthly price and all tirzepatide pricing remain unpublished
GobyMeds

Graded #140 · C

Strengths

  • Aggressively low monthly pricing
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard